Skip to main content

Drugs

Ausgabe 15/2015

Inhalt (12 Artikel)

Current Opinion

Overactive Bladder and the β3-Adrenoceptor Agonists: Current Strategy and Future Prospects

Ilias Giarenis, Dudley Robinson, Linda Cardozo

Open Access Therapy in Practice

Challenges in the Diagnosis and Treatment of Homozygous Familial Hypercholesterolemia

Matthew K. Ito, Gerald F. Watts

Therapy in Practice

Management of Hematologic Malignancies: Special Considerations in Pregnant Women

Odelia Amit, Merav Barzilai, Irit Avivi

Review Article

Prognostic and Predictive Value of RAS Gene Mutations in Colorectal Cancer: Moving Beyond KRAS Exon 2

Nele Boeckx, Marc Peeters, Guy Van Camp, Patrick Pauwels, Ken Op de Beeck, Vanessa Deschoolmeester

Adis Drug Evaluation

Ruxolitinib: A Review in Polycythaemia Vera

Kate McKeage

Adis Drug Evaluation

Saxagliptin: A Review in Type 2 Diabetes

Sohita Dhillon

Adis Drug Evaluation

Tolvaptan: A Review in Autosomal Dominant Polycystic Kidney Disease

Hannah A. Blair, Gillian M. Keating

AdisInsight Report

Flibanserin: First Global Approval

Emma D. Deeks

AdisInsight Report

Cobimetinib: First Global Approval

Karly P. Garnock-Jones

Aktuelle Ausgaben